Quarterly report pursuant to Section 13 or 15(d)

Condensed Consolidated Statements of Operations and Comprehensive Loss (Unaudited)

v3.21.2
Condensed Consolidated Statements of Operations and Comprehensive Loss (Unaudited) - USD ($)
3 Months Ended 6 Months Ended
Jun. 30, 2021
Jun. 30, 2020
Jun. 30, 2021
Jun. 30, 2020
Operating expenses:        
Research and development $ 1,476,430 $ 832,503 $ 2,683,209 $ 1,176,910
General and administrative 615,965 631,629 1,303,901 1,423,236
Total operating expenses 2,092,395 1,464,132 3,987,110 2,600,146
Loss from operations (2,092,395) (1,464,132) (3,987,110) (2,600,146)
Other income:        
Interest income 12,226 18,322 22,922 63,459
Net loss (2,080,169) (1,445,810) (3,964,188) (2,536,687)
Other comprehensive income (loss):        
Foreign currency translation gain (loss) (55) 3,457 2,717 (584)
Comprehensive loss $ (2,080,224) $ (1,442,353) $ (3,961,471) $ (2,537,271)
Net loss per share:        
Basic and diluted $ (0.17) $ (0.14) $ (0.32) $ (0.24)
Weighted average shares outstanding:        
Basic and diluted 12,569,933 10,648,285 12,355,867 10,628,635